|
"Comparative gene resequencing in mouse cancer models"
|
1K08CA160658-01
|
$178,880
|
$89,440
|
McFadden, David
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer
|
1R21CA162602-01A1
|
$375,713
|
$375,713
|
Larson, Steven
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-04
|
$214,879
|
$214,879
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
2010 Mammary Gland Biology GRC
|
5R13CA150225-02
|
$6,000
|
$3,000
|
JERRY, D
|
GORDON RESEARCH CONFERENCES
|
|
3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells
|
5R21CA151159-02
|
$194,941
|
$194,941
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
4th International Symposium on Cancer Metastasis and the Lymphovascular System
|
1R13CA159759-01
|
$3,000
|
$3,000
|
LEONG, STANLEY
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
5th International Conference on Epithelial Mesenchymal Transition
|
1R13CA159537-01
|
$4,000
|
$1,400
|
RUNYAN, RAYMOND
|
UNIVERSITY OF ARIZONA
|
|
A 3D microfluidic platform for quantitative assessments of tumor cell migration
|
5R21CA138366-02
|
$156,844
|
$156,844
|
Wu, Mingming
|
CORNELL UNIVERSITY ITHACA
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-04
|
$381,417
|
$381,417
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-02
|
$302,919
|
$302,919
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A Human Intraepithelial Tumor Microenvironment Assay
|
5R42CA118684-03
|
$550,042
|
$550,042
|
Allen-Hoffmann, Barbara
|
STRATATECH CORPORATION
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-14S1
|
$49,857
|
$16,453
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-14
|
$291,193
|
$96,094
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Method to Direct the Human Immune System Against Metastatic Cancer Cells
|
1F32CA144383-01A1
|
$48,398
|
$48,398
|
Jakobsche, Charles
|
YALE UNIVERSITY
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$94,010
|
$94,010
|
Kelly, Kathleen
|
CCR (NCI)
|
|
A novel combination therapy for the treatment of Pancreatic adenocarcinoma
|
1R03CA149857-01A1
|
$74,250
|
$37,125
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A Novel Dose Calculation Method for Targeted Radionuclide Therapy
|
5R01CA138986-02
|
$316,380
|
$158,190
|
MOURTADA, FIRAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A novel function of TIMP-1
|
5R01CA089113-09
|
$261,358
|
$65,340
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
A novel growth regulatory factor in breast cells
|
5R01CA092440-09
|
$304,580
|
$76,145
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$285,918
|
$200,142
|
Merlino, Glenn
|
CCR (NCI)
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
1R01CA150182-01A1
|
$296,474
|
$296,474
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A program of immune-based treatments for cancer
|
5K24CA093670-09
|
$183,021
|
$45,755
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
5R01CA131197-04
|
$391,087
|
$391,087
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
5R01CA127735-04
|
$302,919
|
$302,919
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
A Structure/function Analysis of a Tumor Specific Protein
|
7R01CA121289-05
|
$309,624
|
$309,624
|
MALKAS, LINDA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Systems Approach To Iron Metabolism In Cancer Cells
|
1R21CA156133-01A1
|
$181,951
|
$181,951
|
LAUBENBACHER, REINHARD
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-13
|
$827,538
|
$82,754
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A Viral Cytokine as a Promoter of Tumor Progression
|
1R15CA158767-01
|
$412,652
|
$206,326
|
SPENCER, JULIET
|
UNIVERSITY OF SAN FRANCISCO
|
|
A10Tg mice, a model of MDSC development and function in a tumor free environment
|
1F31CA159877-01
|
$32,878
|
$32,878
|
Saleem, Sheinei
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Abl Kinases in growth factor signaling, motility, and invasion
|
5R01CA116784-05
|
$259,510
|
$259,510
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
$769,674
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-35S1
|
$50,000
|
$5,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-02
|
$328,873
|
$328,873
|
Mahajan, Nupam
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Ack1: Activation and Consequences in Prostate Cancer
|
4R01CA120304-03
|
$296,823
|
$296,823
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
ACOSOG Central Specimen Bank
|
3U24CA114736-05S2
|
$167,529
|
$16,753
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
3P01CA128913-04S1
|
$76,630
|
$13,793
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
5P01CA128913-04
|
$2,017,261
|
$363,107
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
ACTIVIN SIGNALING AND REGULATION IN THE COLON
|
5R01CA141057-02
|
$276,251
|
$138,126
|
JUNG, BARBARA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
ADAM17 in pancreatic cancer and pancreatitis
|
1R01CA159222-01
|
$395,872
|
$395,872
|
CRAWFORD, HOWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Adenosine in Tumor-Host Interaction
|
5R01CA138923-02
|
$352,106
|
$88,027
|
DIKOV, MIKHAIL
|
VANDERBILT UNIVERSITY
|
|
Adhesive regulation during cell migration
|
5R01CA085862-12
|
$278,169
|
$278,169
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
5R01CA129140-03
|
$592,478
|
$592,478
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
5R01CA134844-03
|
$312,186
|
$312,186
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-07
|
$381,343
|
$381,343
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced Development of An Integrated CTC Enrichment Technology
|
1R33CA157396-01
|
$225,000
|
$112,500
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Advanced Ultrasonic Evaluation of Sentinel Lymph Nodes
|
2R01CA100183-05A1
|
$240,062
|
$240,062
|
Feleppa, Ernest
|
RIVERSIDE RESEARCH INSTITUTE
|
|
AEG-1: Novel Gene Involved in Malignant Glioma
|
5R01CA134721-03
|
$300,907
|
$300,907
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
AFAP-110 as a cSrc activator in breast cancer
|
4R01CA060731-17
|
$229,005
|
$229,005
|
Flynn, Daniel
|
COMMONWEALTH MEDICAL COLLEGE
|
|
AGAP2 regulates membrane trafficking and migaration of glioblastoma cells
|
5K22CA124578-03
|
$192,024
|
$192,024
|
Nie, Zhongzhen
|
UNIVERSITY OF FLORIDA
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-05
|
$449,390
|
$449,390
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
Total relevant funding to Metastasis for this search: $404,767,176
|